Actinium Pharmaceuticals
ATNM
#10375
Rank
ยฃ23.53 M
Marketcap
ยฃ0.75
Share price
4.21%
Change (1 day)
-27.53%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2025 (TTM): -ยฃ28.56 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are ยฃ0.09 Million. In 2024 the company made an earning of -ยฃ31.92 Million, an increase over its 2023 earnings that were of -ยฃ39.34 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ28.56 Million-10.52%
2024 -ยฃ31.92 Million-18.87%
2023 -ยฃ39.34 Million52.24%
2022 -ยฃ25.85 Million36.61%
2021 -ยฃ18.92 Million11.48%
2020 -ยฃ16.97 Million1.46%
2019 -ยฃ16.73 Million-7.37%
2018 -ยฃ18.06 Million-11.46%
2017 -ยฃ20.4 Million10.67%
2016 -ยฃ18.43 Million15.7%
2015 -ยฃ15.93 Million-14.86%
2014 -ยฃ18.71 Million129.19%
2013 -ยฃ8.17 Million-8.55%
2012 -ยฃ8.93 Million
2010 ยฃ0 M-152.15%
2009 -ยฃ0.02 Million-39.8%
2008 -ยฃ0.03 Million120.29%
2007 -ยฃ0.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-ยฃ28.18 Million-0.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
ยฃ0.14 M-100.51%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.29 B-1,132.71%๐Ÿ‡บ๐Ÿ‡ธ USA